Similar to that observed in ALS, FTD patients, harboring TBK1 mutations is also characterized by TDP-43 inclusions in numerous brain regions and cytoplasmic p62 and ubiquitin-positive inclusions in glial cells (Van Mossevelde et al., 2016). This evidence concerns the gene TBK1 and frontotemporal dementia.